Poxel Management
Management criteria checks 2/4
Poxel's CEO is Thomas Kuhn, appointed in Jan 2009, has a tenure of 14.17 years. directly owns 5.58% of the company’s shares, worth €1.27M. The average tenure of the management team and the board of directors is 5.8 years and 7.2 years respectively.
Key information
Thomas Kuhn
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.2yrs |
| CEO ownership | 5.6% |
| Management average tenure | 5.8yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -€29m |
| Mar 31 2022 | n/a | n/a | -€26m |
| Dec 31 2021 | n/a | n/a | -€24m |
| Sep 30 2021 | n/a | n/a | -€26m |
| Jun 30 2021 | n/a | n/a | -€28m |
| Mar 31 2021 | n/a | n/a | -€30m |
| Dec 31 2020 | €1m | €271k | -€32m |
| Sep 30 2020 | n/a | n/a | -€30m |
| Jun 30 2020 | n/a | n/a | -€28m |
| Mar 31 2020 | n/a | n/a | -€27m |
| Dec 31 2019 | €478k | €230k | -€26m |
| Sep 30 2019 | n/a | n/a | -€21m |
| Jun 30 2019 | n/a | n/a | -€16m |
| Mar 31 2019 | n/a | n/a | -€7m |
| Dec 31 2018 | €433k | €206k | €1m |
| Sep 30 2018 | n/a | n/a | -€2m |
| Jun 30 2018 | n/a | n/a | -€5m |
| Mar 31 2018 | n/a | n/a | -€14m |
| Dec 31 2017 | €489k | €191k | -€22m |
| Sep 30 2017 | n/a | n/a | -€22m |
| Jun 30 2017 | n/a | n/a | -€22m |
| Mar 31 2017 | n/a | n/a | -€23m |
| Dec 31 2016 | €200k | €145k | -€24m |
Compensation vs Market: Insufficient data to establish whether Thomas's total compensation is reasonable compared to companies of similar size in the UK market.
Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.
CEO
Thomas Kuhn
14.2yrs
Tenure
€1,055,142
Compensation
Mr. Thomas Kuhn, PharmD, MBA co-founded Poxel SA in 2009 and serves as its Chief Executive Officer and its Director since June 23, 2010. Mr. Kuhn joined Merck Serono in 2000, where he held various position...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.2yrs | €1.06m | 5.58% € 1.3m | |
| Co-Founder | 14.2yrs | no data | no data | |
| Co-Founder and Executive VP of Clinical Development & Regulatory Affairs | 14.2yrs | no data | no data | |
| Co-Founder and Senior VP of R&D Pharmacology & Scientific Communication | 14.2yrs | no data | no data | |
| Executive VP & CFO | 5.8yrs | no data | no data | |
| Executive VP & Chief Scientific Officer | 3.2yrs | no data | no data | |
| Senior Vice President of Investor Relations | 1.5yrs | no data | no data | |
| Executive VP | 3.5yrs | no data | no data | |
| Vice President of Human Resources | 1.4yrs | no data | no data | |
| Executive VP of Business Development & President of US Operations | 7.8yrs | no data | no data | |
| Senior Vice President of Medical & President of Poxel Japan | 4.5yrs | no data | no data |
5.8yrs
Average Tenure
Experienced Management: POXELp's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 12.8yrs | €1.06m | 5.58% € 1.3m | |
| Chairman | 7.2yrs | €348.93k | no data | |
| Board Observer | 5.8yrs | no data | no data | |
| Independent Director | 8.2yrs | €93.00k | no data | |
| Independent Director | 7.2yrs | €72.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8yrs | €74.00k | no data | |
| Independent Director | 10.4yrs | €90.00k | no data | |
| Independent Director | 5.8yrs | €52.00k | no data | |
| Member of Scientific Advisory Board | 4.1yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.2yrs
Average Tenure
61yo
Average Age
Experienced Board: POXELp's board of directors are considered experienced (7.2 years average tenure).